MedTrace Logo

Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

NCT03326050 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-02-13

No results posted yet for this study

Summary

gemifloxacin versus ciprofloxacin and rifampicin in treatment of rhinoscleroma

Conditions

  • Rhinoscleroma

Interventions

DRUG

Gemifloxacin

Gemifloxacin 320Mg Oral Tablet once daily

DRUG

Ciprofloxacin

cipro 750 tablet twice daily

DRUG

Rifampicin

Rifampicin 150Mg Capsule twice daily

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed mohamed, lecturer · assiut yunveristy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-28
Primary Completion
2018-09-01
Completion
2018-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326050 on ClinicalTrials.gov